Objectives: Clinical trial of comparison of vitamin D and placebo on serum level of inflammatory and anti-inflammatory cytokines in patients with sepsis
Design: Blocked randomized, double blind, clinical trial study, Single center, controlled placebo, Sample size 160 patients selected in 3 months and block randomized into two groups.
Inclusion criteria: Age greater than 18 years old; sepsis diagnosis and infection source.
Exclusion criteria: Calcium level greater than or equal to 10 mg/dl; Vitamin D intake during 7 days ago; History of parathyroid diseases; End stage renal disease (ESRD)
Interventions: First (intervention) group receive, 300000 unit vitamin D (1 milliliter), Intramuscular (IM) as a single dose. Second (control) group receive, 1 milliliter normal saline as placebo, single dose, intramuscularly.
Main outcome measures: Serum level of Ca, Vitamin D, Interleukin10 and tumor necrosis factor alpha will be checked 3 months after injection. Also, Duration of hospitalization in different wards and mortality rate will be recorded.